AGC Biologics Launches Cellular and Genetic Technologies Division to Boost Nine Market-Approved Products AGC Biologics, a leading Contract Development and Manufacturing Organization (CDMO), has announced the creation of its new Cell and Gene Technologies division. This strategic move is designed…
Positive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints Sinaptica Therapeutics, Inc., a clinical-stage company pioneering personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has announced the publication of positive results from its 52-week Phase 2…
ELIQUENT Life Sciences Acquires Truliant Consulting to Expand Pharmacovigilance Platform ELIQUENT Life Sciences, a global leader in regulatory, quality, and safety consulting, has announced the strategic acquisition of Truliant Consulting, a highly regarded pharmacovigilance, risk management, and regulatory compliance advisory…
Johnson & Johnson Completes Intra-Cellular Therapies Acquisition to Strengthen Neuroscience Leadership Johnson & Johnson (NYSE: JNJ) has officially completed its acquisition of Intra-Cellular Therapies, Inc., further strengthening its position in the neuroscience sector. Intra-Cellular Therapies will now function as a…
Click Therapeutics Unveils New Brand Identity to Strengthen Leadership in Software as Prescription Treatments Click Therapeutics, Inc. (“Click”), a pioneer in the development of prescription medical treatments, has unveiled a new brand identity and website to reflect its evolution and…
Geneoscopy Appoints Amit Bhalla as CFO to Drive Growth and Commercialization Geneoscopy, Inc., a life sciences company focused on advancing gastrointestinal health through innovative diagnostic tests, has announced the appointment of Amit Bhalla as its Chief Financial Officer (CFO). With…
GE HealthCare and FPT Expand AI-Powered Healthcare Partnership Global IT leader FPT Corporation and GE HealthCare have announced an expanded Strategic Cooperation Agreement aimed at driving innovation in AI-powered healthcare solutions. The new partnership marks a shift from project-based engagement…
Sydnexis Receives Positive CHMP Opinion for SYD-101 in Pediatric Myopia Sydnexis, Inc., a pre-commercial biopharmaceutical company, has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for its proprietary…
Saskatchewan Expands Public Coverage for Dexcom CGM Systems The Government of Saskatchewan has officially expanded its public coverage for continuous glucose monitoring (CGM) systems, a decision that is set to improve diabetes care for many residents in the province. Effective…
NanoVibronix Announces Distribution Agreement with Dukehill Healthcare in Australia NanoVibronix, Inc. (NASDAQ: NAOV), a leading medical technology company specializing in non-invasive therapeutic devices, has announced the renewal and expansion of its exclusive three-year distribution agreement with Dukehill Healthcare Pty Ltd.…
Tris Pharma to Present Data on Cebranopadol at AAPM PainConnect Meeting Tris Pharma, Inc., a biopharmaceutical company focused on commercial-stage development, has announced its participation in the upcoming 2025 American Academy of Pain Medicine (AAPM) PainConnect annual meeting. The conference…
ZAP-X Gyroscopic Radiosurgery Platform Debuts at Kaohsiung Show Chwan Memorial Hospital ZAP Surgical Systems, Inc., a leader in non-invasive robotic brain surgery, has announced the installation of Taiwan’s first vault-free ZAP-X® Gyroscopic Radiosurgery® platform at Kaohsiung Show Chwan Memorial Hospital…
